Basilea Pharmaceutica AG BPMUF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 32.69% | 48.57% | 51.28% | 40.24% | 130.36% |
| Total Receivables | 17.05% | 31.06% | 24.29% | 15.22% | 32.32% |
| Inventory | 13.27% | 26.83% | -22.06% | -27.75% | -18.52% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -29.63% | -21.21% | -22.09% | -27.78% | -11.77% |
| Total Current Assets | 23.92% | 38.75% | 30.22% | 20.72% | 58.52% |
|
|
|||||
| Total Current Assets | 23.92% | 38.75% | 30.22% | 20.72% | 58.52% |
| Net Property, Plant & Equipment | -5.72% | 5.56% | 9.29% | 1.31% | 2.04% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -33.00% | -25.01% | 13.38% | 5.08% | -19.98% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -47.49% | -41.21% | -23.29% | -28.89% | 10.94% |
| Total Assets | 17.88% | 31.99% | 25.02% | 15.90% | 49.04% |
|
|
|||||
| Total Accounts Payable | 38.60% | 55.18% | 49.81% | 38.87% | -2.24% |
| Total Accrued Expenses | 38.23% | 54.77% | 27.04% | 17.76% | 59.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -1.57% | 10.20% | 14.28% | 5.94% | 12.99% |
| Total Finance Division Other Current Liabilities | -57.29% | -52.18% | -10.87% | -17.38% | -45.28% |
| Total Other Current Liabilities | -57.29% | -52.18% | -10.87% | -17.38% | -45.28% |
| Total Current Liabilities | 18.80% | 33.02% | 23.46% | 14.44% | 2.86% |
|
|
|||||
| Total Current Liabilities | 18.80% | 33.02% | 23.46% | 14.44% | 2.86% |
| Long-Term Debt | -15.19% | -5.04% | -10.11% | -16.68% | -3.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -17.06% | -7.13% | -2.26% | -9.39% | -2.08% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -24.05% | -14.96% | -6.41% | -13.25% | -21.02% |
| Total Liabilities | -8.33% | 2.63% | -0.40% | -7.67% | -4.22% |
|
|
|||||
| Common Stock & APIC | -1.14% | 10.69% | 14.81% | 6.43% | 13.62% |
| Retained Earnings | 7.31% | -3.78% | -9.24% | -1.26% | -4.62% |
| Treasury Stock & Other | 4.60% | -6.81% | -11.72% | -3.56% | 1.51% |
| Total Common Equity | 54.91% | 73.44% | 80.51% | 67.33% | 594.37% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 54.91% | 73.44% | 80.51% | 67.33% | 594.37% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 54.91% | 73.44% | 80.51% | 67.33% | 594.37% |
|
|
|||||